Grant Private Wealth Management Inc Makes New Investment in UnitedHealth Group Incorporated (NYSE:UNH)

Grant Private Wealth Management Inc bought a new position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) in the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor bought 1,331 shares of the healthcare conglomerate's stock, valued at approximately $673,000.

A number of other institutional investors also recently modified their holdings of UNH. Howard Capital Management Group LLC bought a new position in shares of UnitedHealth Group in the 3rd quarter valued at about $341,000. Principal Financial Group Inc. grew its stake in UnitedHealth Group by 11.3% in the third quarter. Principal Financial Group Inc. now owns 1,778,636 shares of the healthcare conglomerate's stock valued at $1,039,933,000 after purchasing an additional 180,479 shares in the last quarter. Jacobs Levy Equity Management Inc. bought a new stake in shares of UnitedHealth Group during the 3rd quarter worth approximately $319,000. Integrated Wealth Concepts LLC lifted its stake in UnitedHealth Group by 0.9% in the third quarter. Integrated Wealth Concepts LLC now owns 23,828 shares of the healthcare conglomerate's stock valued at $13,932,000 after acquiring an additional 207 shares during the last quarter. Finally, Motley Fool Asset Management LLC grew its holdings in UnitedHealth Group by 3.6% during the third quarter. Motley Fool Asset Management LLC now owns 41,606 shares of the healthcare conglomerate's stock worth $24,269,000 after purchasing an additional 1,449 shares during the period. 87.86% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

UNH has been the topic of a number of research analyst reports. Piper Sandler dropped their price target on UnitedHealth Group from $605.00 to $600.00 and set an "overweight" rating on the stock in a research note on Thursday, January 2nd. StockNews.com upgraded shares of UnitedHealth Group from a "hold" rating to a "buy" rating in a research note on Thursday, January 23rd. Truist Financial reduced their price objective on UnitedHealth Group from $625.00 to $610.00 and set a "buy" rating for the company in a report on Monday, January 6th. HSBC raised UnitedHealth Group from a "hold" rating to a "buy" rating and set a $595.00 price target for the company in a report on Friday, January 10th. Finally, Stephens boosted their target price on shares of UnitedHealth Group from $605.00 to $675.00 and gave the company an "overweight" rating in a research report on Thursday, December 5th. Twenty equities research analysts have rated the stock with a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of "Buy" and a consensus price target of $629.32.

Remove Ads

Insider Buying and Selling at UnitedHealth Group

In related news, Director Timothy Patrick Flynn acquired 1,000 shares of the stock in a transaction dated Friday, January 17th. The stock was bought at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the transaction, the director now directly owns 4,500 shares of the company's stock, valued at $2,302,065. The trade was a 28.57 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Corporate insiders own 0.33% of the company's stock.

UnitedHealth Group Price Performance

NYSE UNH traded down $15.50 during trading on Friday, hitting $524.94. 9,914,705 shares of the company's stock were exchanged, compared to its average volume of 4,265,629. The company has a market cap of $480.17 billion, a PE ratio of 33.87, a P/E/G ratio of 1.37 and a beta of 0.62. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The stock's 50 day moving average price is $509.39 and its two-hundred day moving average price is $542.82. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $630.73.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, topping analysts' consensus estimates of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The firm had revenue of $100.81 billion for the quarter, compared to analysts' expectations of $101.60 billion. During the same quarter in the previous year, the firm posted $5.83 earnings per share. The company's revenue was up 6.8% on a year-over-year basis. Research analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were given a dividend of $2.10 per share. The ex-dividend date of this dividend was Monday, March 10th. This represents a $8.40 annualized dividend and a yield of 1.60%. UnitedHealth Group's dividend payout ratio is presently 54.19%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.